Professor- Clinical & Experimental Pharmacology, University of Adelaide

Andrew is Professor in Clinical and Experimental Pharmacology.

He is a practicing pharmacist, and a teacher of pharmacology in undergraduate medicine, dentistry, nursing and health science programs. He has an active research program centred on elucidating the dispositional mechanisms for altered human drug response in pain therapeutics, cancer and transplantation through pharmacokinetic, metabolism, pharmacodynamic and pharmacogenomic studies. He has translated his research into clinical practice by establishing a Pharmacogenetics Service at the Royal Adelaide Hospital. Pharmacogenomics and personalised healthcare is a theme of his overarching research and public health focus.

Andrew's research program has been funded by the NHMRC continuously since 1999 and has had NIH, Leukaemia & Lymphoma Society (USA), National Heart Foundation, Alcohol Education and Research, Kidney Australia and ANZCA support over the last 5 years .

He provides regular consultancy on the role of pharmacogenomics in adverse drug reactions to clinicians, patients and the legal profession Australia-wide.

Experience

  • 1992–2010
    Deputy Head, Department of Clinical & Experimental Pharmacology, University of Adelaide
  • 2005–2010
    Associate Dean, Faculty of Health Sciences, University of Adelaide
  • 1982–1992
    Research Fellow, Department of Clinical & Experimental Pharmacology, University of Adelaide

Education

  •  
    University of Sydney, Diploma of Hospital Pharmacy
  •  
    University of Bonn, Postdoctoral Research
  • 1982 
    University of Sydney, PhD (Clinical Pharmacology)
  • 1978 
    University of Sydney, Master of Science
  • 1972 
    Tasmanian College of Advanced Education , PhC (Certificate of Pharmacy)

Grants and Contracts

  • 2011
    TIR Signalling pathway pharmacogenomics and opioid response: beyond the mu opioid receptor
    Role:
    Funding Source:
    National Health and Medical Research Council
  • 2009
    The role of OCT-1 Activity enhancers in improving the response of patients with low OCT-1 activity t
    Role:
    Funding Source:
    Leukemia and Lymphoma Society Translational Resear
  • 2009
    Pharmacogenetics of methadone maintenance treatment
    Role:
    Funding Source:
    National Health and Medical Research Council
  • 2009
    Pharmacogenomics of renal transplantation
    Role:
    Funding Source:
    National Health and Medical Research Council
  • 2009
    The cognitive impact of opioids during chronic administration
    Role:
    Funding Source:
    National Health and Medical Research Council

Research Areas

  • Clinical Pharmacology And Therapeutics (111502)

Honours

2007: Best Oral Presentation in Clinical Toxicology- 10th International Congress of IATDMCT (Nice, France)

2010: Honorary Fellow of the Faculty of Pain Medicine (Australian and New Zealand College of Anaesthetists)